Literature DB >> 30415452

Self-reported disease severity in women with systemic lupus erythematosus.

A Dima1,2, S Caraiola3,4, C Delcea3,4, R A Ionescu3,4, C Jurcut5, C Badea3,4.   

Abstract

Systemic lupus erythematosus (SLE), pathology with net feminine predominance, is one of the most complex autoimmune diseases and has major impact on patients' life. The aim is to identify patient and disease-related factors associated with self-perceived disease severity in female SLE patients. This cross-sectional study enrolled 73 women fulfilling the 2012 Systemic Lupus International Collaborating Clinic (SLICC) criteria. SLE disease activity was assessed by the Systemic Lupus Activity Measure (SLAM) score and overall damage by the SLICC/American College of Rheumatology (ACR) index. Patients' general characteristics, associated conditions as well as SLE specific clinical involvements and therapeutic principles were also noted. Fatigue was assessed by FACIT-fatigue scale. Self-perceived disease severity was assessed using numerical rating scales (1-10 NRSs), to evaluate the disease severity at inclusion (1-10 NRS now) and worst severity anytime during disease history (1-10 NRS worst ever). In regard to worst ever lupus severity, 54.8% of patients responded with 9 or 10, while none with 1 or 2 even if only 22.9% of the patients responded with 7 or more for disease severity at inclusion (1-10 NRS now). Women with higher 1-10 NRS now answers had also higher 1-10 NRS worst ever, SLAM, SLICC, and FACIT-fatigue scores. They associated more frequently anxiety/depression diagnosis, antiphospholipid syndrome, joint involvement as well as treatments with corticosteroids. Self-reported disease severity worst ever, anxiety/depression diagnosis, fatigue, and the daily dose of corticosteroids were independently associated with patients' perception on lupus severity at inclusion: OR (95% CI), 2.13 (1.15-3.94) p = 0.017, 6.67 (1.11-39.97) p = 0.038, 1.10 (1.02-1.19) p = 0.018, and 1.11 (1.02-1.21) p = 0.020, respectively. The vast majority of patients identified severe and very severe events during their disease history, results that raise awareness of burden concerning lupus occurrence in women's life. Self-perceived lupus severity is multifactorial, influenced also by factors less considered in the SLE management like fatigue and the depression/anxiety disorders, but also by the previous patient's experience.

Entities:  

Keywords:  Disease activity; Fatigue; Self-rated health; Systemic lupus erythematosus; Women’s health

Mesh:

Substances:

Year:  2018        PMID: 30415452     DOI: 10.1007/s00296-018-4203-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

Review 1.  Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review.

Authors:  Marianne Jensen Hjermstad; Peter M Fayers; Dagny F Haugen; Augusto Caraceni; Geoffrey W Hanks; Jon H Loge; Robin Fainsinger; Nina Aass; Stein Kaasa
Journal:  J Pain Symptom Manage       Date:  2011-06       Impact factor: 3.612

Review 2.  Patient participation in a Clinical Guideline Development for Systemic Lupus Erythematosus.

Authors:  Pedro Serrano-Aguilar; Maria del Mar Trujillo-Martin; Abraham Pérez de la Rosa; Leticia Cuellar-Pompa; Hugo Saavedra-Medina; Renata Linertova; Lilisbeth Perestelo-Perez; Jeanette Perez-Ramos; Amado Rivero-Santana
Journal:  Patient Educ Couns       Date:  2015-06-11

Review 3.  [Biological causes of depression in Systemic Lupus Erythematosus].

Authors:  J Braga; A Campar
Journal:  Acta Reumatol Port       Date:  2014 Jul-Sep       Impact factor: 1.290

4.  Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus.

Authors:  M Kosinski; K Gajria; A W Fernandes; D Cella
Journal:  Lupus       Date:  2013-02-19       Impact factor: 2.911

5.  Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Vibeke Strand; Hong Fang; Jawali Jaranilla; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

Review 6.  [Depression as a common complication of systemic lupus erythematosus].

Authors:  B Lemaire; D Geron; O Malaise; J M Krzesinski; M Ansseau; G Scantamburlo
Journal:  Rev Med Liege       Date:  2015-04

7.  Understanding remission in real-world lupus patients across five European countries.

Authors:  M Schneider; M Mosca; J M Pego-Reigosa; E Hachulla; L-S Teh; A Perna; V Koscielny; J Pike; S Lobosco; G Apolone
Journal:  Lupus       Date:  2015-12-02       Impact factor: 2.911

8.  Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ).

Authors:  Isabel Castrejón; Yusuf Yazici; Jonathan Samuels; George Luta; Theodore Pincus
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-06       Impact factor: 4.794

9.  Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada.

Authors:  Francis Fatoye; Tadesse Gebrye; Lawrence W Svenson
Journal:  Rheumatol Int       Date:  2018-07-09       Impact factor: 2.631

Review 10.  Physician-patient communication in rheumatology: a systematic review.

Authors:  Sofia Georgopoulou; Louise Prothero; David P D'Cruz
Journal:  Rheumatol Int       Date:  2018-03-26       Impact factor: 2.631

View more
  2 in total

1.  Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity.

Authors:  Elisabet Svenungsson; Iva Gunnarsson; Vera Illescas-Bäckelin; Estelle Trysberg; Andreas Jönsen; Dag Leonard; Christopher Sjöwall; Susanne Pettersson
Journal:  Lupus Sci Med       Date:  2021-05

2.  High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus.

Authors:  Rachel Koelmeyer; Hieu Tri Nim; Mandana Nikpour; Ying B Sun; Amy Kao; Oliver Guenther; Eric Morand; Alberta Hoi
Journal:  Lupus Sci Med       Date:  2020-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.